Navigation Links
Sayles Werbner Earns Rare Texas Supreme Court Ruling Upholding Punitive Damages Award in Medical Malpractice Case
Date:9/2/2008

AUSTIN, Texas, Sept. 2 /PRNewswire/ -- Attorneys from the Dallas litigation firm Sayles Werbner are announcing a rare Supreme Court of Texas opinion upholding a medical malpractice award for the family of a man who died of a heart attack after waiting 12 hours for treatment following his admission to a hospital emergency room for chest pains.

The opinion issued by the high court on Friday in Columbia Medical Center of Los Colinas Inc. d/b/a Las Colinas Medical Center v. Athena Hogue, et al., No. 04-0575, affirms an earlier appeals court holding of negligence against Columbia Medical, as well as actual and gross negligence damages. The opinion also reversed an award for loss of inheritance damages.

Attorneys from Sayles Werbner represented the wife and family of Robert Hogue Jr. in the trial heard in Dallas state district court in 2001. Mr. Hogue died in 1998 after waiting hours for treatment at the Las Colinas Medical Center near Dallas. Jurors awarded $9.2 million in compensatory damages and $21 million in actual damages after the Sayles Werbner team presented evidence that Mr. Hogue's treatment was delayed because of poor hospital policies and lack of staffing.

The 5th Court of Appeals in Dallas reduced the total award to approximately $5.4 million in 2004 based on existing Texas laws limiting damage awards in health care claims. The case had been pending at the Supreme Court of Texas since the appeals court ruling.

Mr. Hogue's son, Christopher Hogue, was a first-year law student at Texas Tech University School of Law when the jury verdict was returned. He now works as an attorney at Sayles Werbner.

"We are extremely pleased to finally have this case resolved through this just, but infrequent affirmance of punitive damages," says attorney Mark Werbner, co-founder of Sayles Werbner and trial counsel for the Hogue family. "This opinion is especially gratifying because the Hogues have had to wait so long for the court to rule
'/>"/>

SOURCE Sayles Werbner
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Broad Institute earns grant to support pathbreaking diabetes study
2. HealthMedia Health Risk Assessment Earns Prestigious NCQA Certification
3. Pharmavite Partners With LearnSomething, Inc. on Consumer Education Program, LearnSomethingAbout(TM)
4. Researchers develop neural implant that learns with the brain
5. Emdeon Assistant Earns HFMAs Peer Review Designation
6. The University of Arizona Program in Integrative Medicine Earns Center of Excellence Designation
7. Florida Tech student earns first place in national science competition
8. Mutual Protection Trust Earns Third A+ Rating From A.M. Best
9. TriWest Earns URAC Health Network Reaccreditation
10. Woodland Park Care Center Earns Quality Respiratory Care Recognition
11. United Heartland Group Program Earns Record Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Royalty Pharma Announces that Alexander von Perfall Joins Management Team 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Simulation helps students learn dental implant procedures 48631 1Simulation helps students learn dental implant procedures 48631 2Simulation helps students learn dental implant procedures 48631 3U S Drug Czar Addresses 2 500 Drug Court Professionals Voices Strong Support for Expanding Drug Courts Throughout the Nation 48628 1U S Drug Czar Addresses 2 500 Drug Court Professionals Voices Strong Support for Expanding Drug Courts Throughout the Nation 48628 2U S Drug Czar Addresses 2 500 Drug Court Professionals Voices Strong Support for Expanding Drug Courts Throughout the Nation 48628 3Are angiotensins involved in the hemodynamic changes of cirrhosis patients 3F 48625 1Are angiotensins involved in the hemodynamic changes of cirrhosis patients 3F 48625 2